Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents by C. Gastaldon, G. Schoretsanitis, E. Arzenton, E. Raschi, D. Papola, G. Ostuzzi, U. Moretti, E. Seifritz, J. M. Kane, G. Trifirò, C. Barbui

“…Trifirò Grant / Research support from: he was the scientific director of a Master program on pharmacovigilance, pharmacoepidemiology and real-world evidence which has received non-conditional grant from various pharmaceutical companies; he coordinated a pharmacoepidemiology team at the University of Messina until Oct 2020, which has received funding for conducting observational studies from various pharmaceutical companies (Boehringer Ingelheim, Daichii Sankyo, PTC Pharmaceuticals). …”
Get full text